News
ENTX
1.170
0.00%
0.000
Greenberg Traurig Represents Israel-based Entera Bio in $10M Private Placement Led by BVF Partners
PR Newswire · 2d ago
Entera Bio Prices $10 Mln Private Placement Of Shares And Warrants; Stock Down
NASDAQ · 2d ago
Weekly Report: what happened at ENTX last week (0330-0403)?
Weekly Report · 2d ago
Entera Bio Announces $10 Million Private Placement Financing
TipRanks · 5d ago
Entera Bio prices $10M direct investment, sees up to $24.5M in total proceeds
Seeking Alpha · 6d ago
Entera Bio Raises $10M In Private Placement Led by BVF Partners, With Potential To Reach $24.5M
Benzinga · 6d ago
Stock Market Today: S&P 500, Dow Futures Gain As Trump Calls Iran's New Leaders 'Very Reasonable'—Palantir, Rezolve AI, Entera Bio In Focus
Benzinga · 03/30 09:27
Weekly Report: what happened at ENTX last week (0323-0327)?
Weekly Report · 03/30 09:08
Phreesia, Progress Software And 3 Stocks To Watch Heading Into Monday
Benzinga · 03/30 07:29
Entera Bio Reports 2025 Results, Advances Oral Osteoporosis Pipeline
TipRanks · 03/27 20:38
Entera Bio GAAP EPS of -$0.25 beats by $0.03, revenue of $0.04M in-line
Seeking Alpha · 03/27 20:30
Entera Bio Q4 EPS $(0.06) Beats $(0.09) Estimate
Benzinga · 03/27 20:10
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates
Barchart · 03/27 15:05
Entera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market
TipRanks · 03/23 13:30
Weekly Report: what happened at ENTX last week (0316-0320)?
Weekly Report · 03/23 09:08
Weekly Report: what happened at ENTX last week (0309-0313)?
Weekly Report · 03/16 09:08
Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy
TipRanks · 03/12 13:00
Entera Bio Insider Makes Bold New Move on the Stock
TipRanks · 03/12 02:02
Insider Makes Bold Move on Entera Bio Shares
TipRanks · 03/10 02:09
Weekly Report: what happened at ENTX last week (0302-0306)?
Weekly Report · 03/09 09:08
More
Webull provides a variety of real-time ENTX stock news. You can receive the latest news about Entera Bio Ltd through multiple platforms. This information may help you make smarter investment decisions.
About ENTX
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.